A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination

Authors: Ramesh K. Ramanathan, James L. Abbruzzese, Tomislav Dragovich, Lynn Kirkpatrick, Jose Guillen, Amanda F. Baker, Linda Pestano, Sylvan Green, Daniel D. Von Hoff - Cancer Chemotherapy and Pharmacology 2010 cited by 119